Document Detail


Comparison of the effect of blood cardioplegia to crystalloid cardioplegia on myocardial contractility in man.
MedLine Citation:
PMID:  6968855     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
The myocardial protection achieved by blood cardioplegia was compared to that achieved by crystalloid cardioplegia in a randomized prospective series of patients having coronary bypass operations. Group BCP (n = 15) was protected with 10 degrees C blood containing potassium, 30 mEq/L; Group KCP (n = 9) by an electrolyte solution at 4 degrees C with mannitol, 25 gm/L, and potassium, 26 mEq/L, and group MgKCP (n = 9) by an electrolyte solution at 4 degrees C containing magnesium, 30 Meq/L, and potassium, 19.6 mEq/L. The three groups were comparable in regard to age, sex, preoperative left ventricular function, symptoms, propranolol use, previous myocardial infarction, number of vessels bypassed, and duration of ischemic arrest. In each patient cardiac output, left ventricular end-diastolic pressure (LVEDP), and maximum contractile element velocity (Vpm) were recorded before and after the ischemic period. All operations were performed in an identical manner with one continuous period of aortic cross-clamping averaging 52.9 minutes. No significant alterations in myocardial function were observed after ischemia within the BCP or KCP groups. However, patients receiving MgKCP had significant (p = 0.02) depression in Vpm from 2.86 +/- 7.8 to 2.04 +/- 3.6 second-1 and increase (p < 0.05) in LVEDP from 9.4 +/- 2.2 to 13.4 +/- 5.2 mm Hg. Analysis of variance between groups showed that Vpm decreased significantly (p < 0.05) and LVEDP increased significantly (p < 0.05) in the MgKCP group by comparison to the BCP group. Patients receiving BCP experienced spontaneous defibrillation more frequently (p < 0.02) and received nitroprusside postoperatively more often (p < 0.05) than patients in the other two groups. From these results we conclude that blood cardioplegia provides excellent protection during myocardial ischemia, probably better than one of the two crystalloid solutions tested but no better than the other crystalloid solution. Because the three solutions differed from one another in several respects, no conclusion can be reached about the efficacy of any one ingredient.
Authors:
N Shapira; M Kirsh; K Jochim; D M Behrendt
Related Documents :
22161615 - Sonographic assessment of fetal cardiac function: indirect measurements of fetal cardia...
17281115 - Activation of mitochondrial atp-sensitive potassium channel contributes to protective e...
8649135 - The importance of glucose-insulin-potassium with cardiopulmonary bypass prior to cardio...
12062265 - Delayed sternal closure: a life-saving measure in neonatal open heart surgery; could it...
24826235 - Correlation between t-wave alternans and cardiac volume status via intrathoracic impeda...
16275525 - Transthoracic doppler echocardiographic assessment of coronary flow velocity pattern in...
Publication Detail:
Type:  Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial    
Journal Detail:
Title:  The Journal of thoracic and cardiovascular surgery     Volume:  80     ISSN:  0022-5223     ISO Abbreviation:  J. Thorac. Cardiovasc. Surg.     Publication Date:  1980 Nov 
Date Detail:
Created Date:  1981-01-29     Completed Date:  1981-01-29     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  0376343     Medline TA:  J Thorac Cardiovasc Surg     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  647-55     Citation Subset:  AIM; IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Anti-Arrhythmia Agents / pharmacology*
Blood
Cardiac Output / drug effects
Coronary Artery Bypass*
Female
Heart Arrest, Induced / methods*
Hemodynamics / drug effects
Humans
Hypothermia, Induced
Magnesium / pharmacology*
Male
Middle Aged
Myocardial Contraction / drug effects*
Potassium / pharmacology*
Random Allocation
Solutions
Chemical
Reg. No./Substance:
0/Anti-Arrhythmia Agents; 0/Solutions; 7439-95-4/Magnesium; 7440-09-7/Potassium

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Characterization of in vivo suppression of syngenic tumor by allogenic effector cells.
Next Document:  Diagnosis, stage, and prognosis of lung carcinoma by preoperative assay of lung tumor antigen-sensit...